{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:10:10Z","timestamp":1762866610358},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,19]],"date-time":"2015-04-19T00:00:00Z","timestamp":1429401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11255-015-0976-2","type":"journal-article","created":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T07:33:19Z","timestamp":1429342399000},"page":"893-898","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Delayed contrast-enhanced MRI to localize Botox after cystoscopic intravesical injection"],"prefix":"10.1007","volume":"47","author":[{"given":"Mazen","family":"Alsinnawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Torreggiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazher","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Donnellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. E. D.","family":"Mcdermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Thornhill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,19]]},"reference":[{"issue":"4","key":"976_CR1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","volume":"50","author":"AK Patel","year":"2006","unstructured":"Patel AK, Patterson JM, Chapple CR (2006) Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results. Eur Urol 50(4):684\u2013709","journal-title":"Eur Urol"},{"key":"976_CR2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, St\u00f6hrer M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692\u2013697","journal-title":"J Urol"},{"issue":"1","key":"976_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","volume":"55","author":"A Apostolidis","year":"2009","unstructured":"Apostolidis A, Dasgupta P, Denys P et al (2009) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 55(1):100\u2013119","journal-title":"Eur Urol"},{"issue":"1","key":"976_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","volume":"176","author":"DM Schmid","year":"2006","unstructured":"Schmid DM, Sauermann P, Werner M et al (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176(1):177\u2013185","journal-title":"J Urol"},{"issue":"3","key":"976_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00345-008-0362-0","volume":"27","author":"U Mehnert","year":"2009","unstructured":"Mehnert U, Boy S, Schmid M et al (2009) A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging. World J Urol 27(3):397\u2013403","journal-title":"World J Urol"},{"key":"976_CR6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","volume":"178","author":"HC Kuo","year":"2007","unstructured":"Kuo HC (2007) Comparison of effectiveness of detrusor suburothelial and bladder base injections of botulinum toxin A for idiopathic detrusor overactivity. J Urol 178:1359\u20131363","journal-title":"J Urol"},{"issue":"5","key":"976_CR7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1520-6777(2000)19:5<585::AID-NAU5>3.0.CO;2-U","volume":"19","author":"OW Hakenberg","year":"2000","unstructured":"Hakenberg OW, Linne C, Manseck A, Wirth MP (2000) Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement. Neurourol Urodyn 19(5):585\u2013593","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"976_CR8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.urology.2009.04.081","volume":"74","author":"AD Rule","year":"2009","unstructured":"Rule AD, St Sauver JL, Jacobson DJ et al (2009) Three-dimensional ultrasound bladder characteristics and their association with prostate size and lower urinary tract dysfunction among men in the community. Urology 74(4):908\u2013913","journal-title":"Urology"},{"issue":"4","key":"976_CR9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49(4):644\u2013650","journal-title":"Eur Urol"},{"key":"976_CR10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1464-410X.2003.04722.x","volume":"93","author":"CM Brady","year":"2004","unstructured":"Brady CM, Apostolidis A, Harper M et al (2004) Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment. BJU Int 93:770\u2013776","journal-title":"BJU Int"},{"key":"976_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2003.12.017","volume":"46","author":"C Brady","year":"2004","unstructured":"Brady C, Apostolidis A, Yiangou Y et al (2004) P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin (RTX). Eur Urol 46:247\u2013253","journal-title":"Eur Urol"},{"issue":"6","key":"976_CR12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.eururo.2012.01.046","volume":"61","author":"A Coelho","year":"2012","unstructured":"Coelho A, Cruz F, Cruz CD, Avelino A (2012) Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action. Eur Urol 61(6):1178\u20131184","journal-title":"Eur Urol"},{"key":"976_CR13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","volume":"66","author":"HC Kuo","year":"2005","unstructured":"Kuo HC (2005) Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology 66:94\u201398","journal-title":"Urology"},{"issue":"5","key":"976_CR14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.eururo.2011.12.005","volume":"61","author":"CR Chapple","year":"2012","unstructured":"Chapple CR (2012) Which preparation of botulinum toxin A should be used, where should it be injected, and how should its efficacy be assessed? Eur Urol 61(5):936\u2013937","journal-title":"Eur Urol"},{"issue":"5","key":"976_CR15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.eururo.2011.10.043","volume":"61","author":"RP Manecksha","year":"2012","unstructured":"Manecksha RP, Cullen IM, Ahmad S et al (2012) Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity. Eur Urol 61(5):928\u2013935","journal-title":"Eur Urol"},{"key":"976_CR16","first-page":"24","volume":"71","author":"DD Dykstra","year":"1990","unstructured":"Dykstra DD, Sidi AA (1990) Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 71:24\u201326","journal-title":"Arch Phys Med Rehabil"},{"key":"976_CR17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.sc.3101318","volume":"40","author":"JJ Wyndaele","year":"2002","unstructured":"Wyndaele JJ, van Dromme SA (2002) Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40:599\u2013600","journal-title":"Spinal Cord"},{"key":"976_CR18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.sc.3101736","volume":"43","author":"K Laet De","year":"2005","unstructured":"De Laet K, Wyndaele JJ (2005) Adverse events after botulinumA toxin injection for neurogenic voiding disorders. Spinal Cord 43:397\u2013399","journal-title":"Spinal Cord"},{"key":"976_CR19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1464-410X.2006.06091.x","volume":"97","author":"A Ruffion","year":"2006","unstructured":"Ruffion A, Capelle O, Paparel P, Leriche B, Leriche A, Grise P (2006) What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int 97:1030\u20131034","journal-title":"BJU Int"},{"key":"976_CR20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","volume":"53","author":"G Popolo Del","year":"2008","unstructured":"Del Popolo G, Filocamo MT, Li Marzi V et al (2008) Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre. Eur Urol 53:1013\u20131019","journal-title":"Eur Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-0976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-0976-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-0976-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:02:01Z","timestamp":1559390521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-0976-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,19]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-0976-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,19]]}}}